210 related articles for article (PubMed ID: 37450380)
41. Expression of CDKN1C in the bone marrow of patients with myelodysplastic syndrome and secondary acute myeloid leukemia is associated with poor survival after conventional chemotherapy.
Radujkovic A; Dietrich S; Andrulis M; Benner A; Longerich T; Pellagatti A; Nanda K; Giese T; Germing U; Baldus S; Boultwood J; Ho AD; Dreger P; Luft T
Int J Cancer; 2016 Sep; 139(6):1402-13. PubMed ID: 27170453
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of WNT signaling in the bone marrow niche prevents the development of MDS in the
Stoddart A; Wang J; Hu C; Fernald AA; Davis EM; Cheng JX; Le Beau MM
Blood; 2017 Jun; 129(22):2959-2970. PubMed ID: 28348148
[TBL] [Abstract][Full Text] [Related]
43. Hematopathological alterations of major tumor suppressor cascade, vital cell cycle inhibitors and hematopoietic niche components in experimental myelodysplasia.
Chatterjee R; Gupta S; Law S
Chem Biol Interact; 2017 Aug; 273():1-10. PubMed ID: 28549617
[TBL] [Abstract][Full Text] [Related]
44. Haplodeficiency of the 9p21 tumor suppressor locus causes myeloid disorders driven by the bone marrow microenvironment.
Feng J; Hsu PF; Esteva E; Labella R; Wang Y; Khodadadi-Jamayran A; Pucella J; Liu CZ; Arbini AA; Tsirigos A; Kousteni S; Reizis B
Blood; 2023 Aug; 142(5):460-476. PubMed ID: 37267505
[TBL] [Abstract][Full Text] [Related]
45. Effects of rigosertib on the osteo-hematopoietic niche in myelodysplastic syndromes.
Balaian E; Weidner H; Wobus M; Baschant U; Jacobi A; Mies A; Bornhäuser M; Guck J; Hofbauer LC; Rauner M; Platzbecker U
Ann Hematol; 2019 Sep; 98(9):2063-2072. PubMed ID: 31312928
[TBL] [Abstract][Full Text] [Related]
46. Alterations within the Osteo-Hematopoietic Niche in MDS and their Therapeutic Implications.
Mies A; Bulycheva E; Rogulj IM; Hofbauer LC; Platzbecker U
Curr Pharm Des; 2016; 22(16):2323-32. PubMed ID: 26916019
[TBL] [Abstract][Full Text] [Related]
47. NUP98-HOX translocations lead to myelodysplastic syndrome in mice and men.
Slape C; Lin YW; Hartung H; Zhang Z; Wolff L; Aplan PD
J Natl Cancer Inst Monogr; 2008; (39):64-8. PubMed ID: 18648006
[TBL] [Abstract][Full Text] [Related]
48. Perturbed hematopoietic stem and progenitor cell hierarchy in myelodysplastic syndromes patients with monosomy 7 as the sole cytogenetic abnormality.
Dimitriou M; Woll PS; Mortera-Blanco T; Karimi M; Wedge DC; Doolittle H; Douagi I; Papaemmanuil E; Jacobsen SE; Hellström-Lindberg E
Oncotarget; 2016 Nov; 7(45):72685-72698. PubMed ID: 27683035
[TBL] [Abstract][Full Text] [Related]
49. Age-related changes of healthy bone marrow cell signaling in response to growth factors provide insight into low risk MDS.
Kornblau SM; Cohen AC; Soper D; Huang YW; Cesano A
Cytometry B Clin Cytom; 2014 Nov; 86(6):383-96. PubMed ID: 24106013
[TBL] [Abstract][Full Text] [Related]
50. Dysfunctional bone marrow endothelial progenitor cells are involved in patients with myelodysplastic syndromes.
Xing T; Lyu ZS; Duan CW; Zhao HY; Tang SQ; Wen Q; Zhang YY; Lv M; Wang Y; Xu LP; Zhang XH; Huang XJ; Kong Y
J Transl Med; 2022 Mar; 20(1):144. PubMed ID: 35351133
[TBL] [Abstract][Full Text] [Related]
51. Induction of acute myeloid leukemia in mice by the human leukemia-specific fusion gene NUP98-HOXD13 in concert with Meis1.
Pineault N; Buske C; Feuring-Buske M; Abramovich C; Rosten P; Hogge DE; Aplan PD; Humphries RK
Blood; 2003 Jun; 101(11):4529-38. PubMed ID: 12543865
[TBL] [Abstract][Full Text] [Related]
52. What is the role of the microenvironment in MDS?
Calvi LM; Li AJ; Becker MW
Best Pract Res Clin Haematol; 2019 Dec; 32(4):101113. PubMed ID: 31779976
[TBL] [Abstract][Full Text] [Related]
53. In vitro characterization of hematopoietic microenvironment cells from patients with myelodysplastic syndrome.
Flores-Figueroa E; Gutiérrez-Espíndola G; Montesinos JJ; Arana-Trejo RM; Mayani H
Leuk Res; 2002 Jul; 26(7):677-86. PubMed ID: 12008086
[TBL] [Abstract][Full Text] [Related]
54. CXCR4 expression in the bone marrow microenvironment is required for hematopoietic stem and progenitor cell maintenance and early hematopoietic regeneration after myeloablation.
Singh P; Mohammad KS; Pelus LM
Stem Cells; 2020 Jul; 38(7):849-859. PubMed ID: 32159901
[TBL] [Abstract][Full Text] [Related]
55. Bone marrow niches in myeloid neoplasms.
Kitagawa M; Kurata M; Onishi I; Yamamoto K
Pathol Int; 2020 Feb; 70(2):63-71. PubMed ID: 31709722
[TBL] [Abstract][Full Text] [Related]
56. Increased expression of interferon signaling genes in the bone marrow microenvironment of myelodysplastic syndromes.
Kim M; Hwang S; Park K; Kim SY; Lee YK; Lee DS
PLoS One; 2015; 10(3):e0120602. PubMed ID: 25803272
[TBL] [Abstract][Full Text] [Related]
57. Myelodysplastic syndrome hematopoietic stem cell.
Li J
Int J Cancer; 2013 Aug; 133(3):525-33. PubMed ID: 23047726
[TBL] [Abstract][Full Text] [Related]
58. Vascular and perivascular niches, but not the osteoblastic niche, are numerically restored following allogeneic hematopoietic stem cell transplantation in patients with aplastic anemia.
Wu L; Mo W; Zhang Y; Zhou M; Li Y; Zhou R; Xu S; Pan S; Deng H; Mao P; Wang S
Int J Hematol; 2017 Jul; 106(1):71-81. PubMed ID: 28303517
[TBL] [Abstract][Full Text] [Related]
59. Reserves, functional, immunoregulatory, and cytogenetic properties of bone marrow mesenchymal stem cells in patients with myelodysplastic syndromes.
Klaus M; Stavroulaki E; Kastrinaki MC; Fragioudaki P; Giannikou K; Psyllaki M; Pontikoglou C; Tsoukatou D; Mamalaki C; Papadaki HA
Stem Cells Dev; 2010 Jul; 19(7):1043-54. PubMed ID: 19788374
[TBL] [Abstract][Full Text] [Related]
60. Analysis of myeloid and lymphoid markers on the surface and in the cytoplasm of mononuclear bone marrow cells in patients with myelodysplastic syndrome.
Schlesinger M; Silverman LR; Jiang JD; Yagi MJ; Holland JF; Bekesi JG
J Clin Lab Immunol; 1996; 48(4):149-66. PubMed ID: 9819667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]